113261-00-0

Basic information

• Product Name: (3-AMINO-PHENYL)-CARBAMIC ACID BENZYL ESTER
• Synonyms: (3-AMINO-PHENYL)-CARBAMIC ACID BENZYL ESTER;(3-Amino-Phenyl)-Carbamic Acid Benzyl Ester(WX602114)
• CAS NO: 113261-00-0
• Molecular Formula: C₁₄H₁₄N₂O₂
• Molecular Weight: 242.27
• Mol File: 113261-00-0.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (3-AMINO-PHENYL)-CARBAMIC ACID BENZYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (3-AMINO-PHENYL)-CARBAMIC ACID BENZYL ESTER(113261-00-0)
• EPA Substance Registry System: (3-AMINO-PHENYL)-CARBAMIC ACID BENZYL ESTER(113261-00-0)

Safety Data

• Hazardous Substances Data: 113261-00-0(Hazardous Substances Data)

Usage

General Description

(3-Amino-phenyl)-carbamic acid benzyl ester is a chemical compound with the molecular formula C15H15N3O2. It is a derivative of carbamic acid with a benzyl ester functional group and an amino-phenyl substituent. (3-AMINO-PHENYL)-CARBAMIC ACID BENZYL ESTER may have applications in organic synthesis and medicinal chemistry due to its unique structure and potential reactivity. Its exact properties and uses would depend on the specific context and intended application, and further research may be necessary to fully understand its potential uses and effects.

Upstream product

• 108-45-2 m-phenylenediamine 
• 1885-14-9 phenyl chloroformate 
• 53821-16-2 (3-nitrophenyl)carbamic acid benzyl ester 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 1604811-22-4 (E)-N-(3-(5-chloro-4-(1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)-4-(4-(dimethylamino)but-2-enamido)-N-methylbenzamide 
• 1604811-96-2 4-amino-N-(3-(5-chloro-4-(1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)-N-methylbenzamide 
• 1604811-94-0 4-amino-N-(3-(5-chloro-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)-N-methylbenzamide 
• 1604811-92-8 tert-butyl 4-((3-(5-chloro-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)(methyl)carbamoyl)phenylcarbamate 
• 1604811-88-2 benzyl N-{3-[N-methyl(4-{[(tert-butoxy)carbonyl]amino}benzene)amido]phenyl}carbamate 
• 1604811-85-9 benzyl 3-(methylamino)phenylcarbamate 
• 1604811-82-6 benzyl 3-(2,2,2-trifluoro-N-methylacetamido)phenylcarbamate 
• 1604811-19-9 (E)-N-(3-(5-chloro-4-(1H-indol-3-yl)pyridin-2-ylamino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide 
• 1604811-67-7 tert-butyl 4-(3-(5-chloro-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyridin-2-ylamino)phenylcarbamoyl)phenylcarbamate 
• 1604811-18-8 (E)-N-(3-(5-cyano-4-(1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide 
• 1604811-63-3 (E)-N-(3-(5-cyano-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide 
• 1604811-62-2 4-amino-N-(3-(5-cyano-4-(1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)benzamide 
• 1604811-60-0 4-amino-N-(3-(5-cyano-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)benzamide 
• 1604811-59-7 4-amino-N-(3-((5-chloro-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide 

Relevant articles and documents

Carbonyl Iron Powder: A Reagent for Nitro Group Reductions under Aqueous Micellar Catalysis Conditions

An especially mild, safe, efficient, and environmentally responsible reduction of aromatic and heteroaromatic nitro-group-containing educts is reported that utilizes very inexpensive carbonyl iron powder (CIP), a highly active commercial grade of iron powder. These reductions are conducted in the presence of nanomicelles composed of TPGS-750-M in water, a recyclable aqueous micellar reaction medium. This new technology also shows broad scope and scalability and presents opportunities for multistep one-pot sequences involving this reducing agent.

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

MAKROTRICYCLIC AND MACROPENTACYCLIC DITOPIC RECEPTOR MOLECULES. SYNTHESIS, CRYSTAL STRUCTURE AND SUBSTRATE BINDING.

A macrocyclic (1), three nacropentacyclic (2a-c) and a macrobicyclic (3b) receptor molecules have been synthesized, via a particularly efficient route for (2b) and (2c).The crystal structures of (1), (2b) and (3b) have been determined and related to some